582313-57-3 Usage
General Description
4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]-pyrimidine is a chemical compound with the molecular formula C6H3ClFN4. It is a heterocyclic organic compound that contains a pyrrolopyrimidine core structure. 4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]-pyrimidine is used in the development of pharmaceutical drugs and is often utilized as a building block in the synthesis of various biologically active molecules. It has also been investigated for its potential use in the treatment of cancer and other diseases. 4-Chloro-5-fluoro-7H-pyrrolo[2,3-d]-pyrimidine plays a crucial role in medicinal chemistry and is an important intermediate in the production of various pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 582313-57-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,2,3,1 and 3 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 582313-57:
(8*5)+(7*8)+(6*2)+(5*3)+(4*1)+(3*3)+(2*5)+(1*7)=153
153 % 10 = 3
So 582313-57-3 is a valid CAS Registry Number.
582313-57-3Relevant articles and documents
Fluorine substituted adenosines as probes of nucleobase protonation in functional RNAs
Suydam, Ian T.,Strobel, Scott A.
, p. 13639 - 13648 (2008)
Ionized nucleobases are required for folding, conformational switching, or catalysis in a number of functional RNAs. A common strategy to study these sites employs nucleoside analogues with perturbed pKa, but the interpretation of these studies
SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5
-
Paragraph 0251, (2020/10/20)
The disclosure is directed to methods of treating disease using compounds of Formula (I).
CYCLIC DINUCLEOTIDES AS STING AGONISTS
-
Page/Page column 288-290, (2019/07/19)
Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein B2,X2, R2a, R2b, R2c, Z-M-Y, Y1-M1Z1, B1, X1, R1a, R1b, R1c are as defined herein.